Recently, hyperosmolar hyponatremia following excessive off-label use of two exchanges of 2 L icodextrin daily during peritoneal dialysis (PD) was reported. We encountered a cluster of 3 cases of PD patients who developed hyperosmolar hyponatremia during on-label use of icodextrin. This appeared to be due to absorption of icodextrin since after stopping icodextrin, the serum sodium level and osmol gap returned to normal, while a rechallenge again resulted in hyperosmolar hyponatremia. We excluded higher than usual concentrations of specific fractions of dextrins in fresh icodextrin dialysis fluid (lot numbers of used batches were checked by manufacturer). We speculate that in our patients, either an exaggerated degradation of polysaccharide chains by α-amylase activity in dialysate, lymph, and interstitium and/or rapid hydrolysis of the absorbed larger degradation products in the circulation may have contributed to the hyperosmolality observed, with the concentration of oligosaccharides exceeding the capacity of intracellular enzymes (in particular maltase) to metabolize these products to glucose. Both hyponatremia and hyperosmolality are risk factors for poor outcomes in PD patients. Less conventional PD prescriptions such as off-label use of two exchanges of 2 L icodextrin might raise the risk of this threatening side effect. This brief report is intended to create awareness of a rare complication of on-label icodextrin use in a subset of PD patients and/or PD prescriptions.

1.
Chaudhari
H
,
Mahendrakar
S
,
Akporotu
A
,
Yudd
M
.
Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis
.
Clin Nephrol Cases
.
2023
;
11
:
61
5
.
2.
Olszowska
A
,
Waniewski
J
,
Stachowska-Pietka
J
,
Garcia-Lopez
E
,
Lindholm
B
,
Wańkowicz
Z
.
Long peritoneal dialysis dwells with icodextrin: kinetics of transperitoneal fluid and polyglucose transport
.
Front Physiol
.
2019
;
10
:
1326
.
3.
Davies
SJ
,
Garcia Lopez
E
,
Woodrow
G
,
Donovan
K
,
Plum
J
,
Williams
P
et al
.
Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange
.
Nephrol Dial Transpl
.
2008
;
23
(
9
):
2982
8
.
4.
Ota
K
,
Akiba
T
,
Nakao
T
,
Nakayama
M
,
Maeba
T
,
Park
MS
et al
.
Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients
.
Perit Dial Int
.
2003
;
23
(
4
):
356
61
.
5.
Pasthuma
N
,
ter Wee
PM
,
Danker
AJ
,
Oe
PL
,
van Dorp
W
,
Peers
EM
et al
.
Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell
.
Perit Dial Int
.
1997
;
17
(
6
):
602
7
.
6.
Hillier
TA
,
Abbott
RD
,
Barrett
EJ
.
Hyponatremia: evaluating the correction factor for hyperglycemia
.
Am J Med
.
1999
;
106
(
4
):
399
403
.
7.
García-López
E
,
Lindholm
B
.
Icodextrin metabolites in peritoneal dialysis
.
Perit Dial Int
.
2009
;
29
(
4
):
370
6
.
8.
Stachowska-Pietka
J
,
Waniewski
J
,
Olszowska
A
,
Garcia-Lopez
E
,
Wankowicz
Z
,
Lindholm
B
.
Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis
.
Sci Rep
.
2023
;
13
(
1
):
6526
.
9.
Weser
E
,
Sleisenger
MH
.
Metabolism of circulating disaccharides in man and the rat
.
J Clin Invest
.
1967
;
46
(
4
):
499
505
.
10.
Gamklou
R
,
Schersten
T
.
Activity of -amylase and -1,4-glucosidase in human liver tissue
.
Scand J Clin Lab Invest
.
1972
;
30
(
2
):
201
7
.
11.
Silver
SA
,
Harel
Z
,
Perl
J
.
Practical considerations when prescribing icodextrin: a narrative review
.
Am J Nephrol
.
2014
;
39
(
6
):
515
27
.
12.
Gradden
CW
,
Ahmad
R
,
Bell
GM
.
Peritoneal dialysis: new developments and new problems
.
Diabet Med
.
2001
;
18
(
5
):
360
3
.
13.
Kunin
M
,
Ganon
L
,
Holtzman
EJ
,
Dinour
D
.
Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: a case series
.
Nefrologia
.
2018
;
38
(
1
):
87
91
.
14.
Brown
EA
,
Blake
PG
,
Boudville
N
,
Davies
S
,
de Arteaga
J
,
Dong
J
et al
.
International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis
.
Perit Dial Int
.
2020
;
40
(
3
):
244
53
.
15.
Arzhan
S
,
Lew
SQ
,
Ing
TS
,
Tzamaloukas
AH
,
Unruh
ML
.
Dysnatremias in chronic kidney disease: pathophysiology, manifestations, and treatment
.
Front Med
.
2021
;
8
:
769287
.
16.
Shaikh
G
,
Sehgal
R
,
Sandhu
S
,
Vaddineni
S
,
Fogel
J
,
Rubinstein
S
.
Changes in osmol gap in chronic kidney disease: an exploratory study
.
Ren Fail
.
2014
;
36
(
2
):
198
201
.
17.
Vareesangthip
K
,
Davenport
A
.
Comparison of measuring serum osmolality and equations estimating osmolality in peritoneal dialysis patients
.
Perit Dial Int
.
2020
;
40
(
5
):
509
12
.
You do not currently have access to this content.